American Heart Journal
Volume 149, Issue 2 , Pages 234-239, February 2005

Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia:

Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial

  • John J.P. Kastelein, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationReprint requests: John J.P. Kastelein, MD, PhD, Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • ,
  • Philip T. Sager, MD

      Affiliations

    • Schering-Plough Research Institute, Kenilworth, NJ
  • ,
  • Eric de Groot, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
  • ,
  • Enrico Veltri, MD

      Affiliations

    • Schering-Plough Research Institute, Kenilworth, NJ

Received 28 January 2004; accepted 29 June 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-8703(04)00550-2

doi:10.1016/j.ahj.2004.06.024

American Heart Journal
Volume 149, Issue 2 , Pages 234-239, February 2005